XNAS: GLSI
Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart
about
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane pepti...
Read More
16.32
-2.69
(-14.15%)
333.3K
XNAS Volume
High volume+loss today
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Greenwich LifeSciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..